LFG
ANIP icon

Larson Financial Group’s ANI Pharmaceuticals ANIP Stock Holding History

Larson Financial Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Buy
328
+100
+44% +$8.02K ﹤0.01% 1834
2026
Q1 		$17.5K Buy
228
+77
+51% +$6.01K ﹤0.01% 1919
2025
Q4 		$11.9K Buy
+151
New +$13.1K ﹤0.01% 2017
2025
Q3 		– Sell
-2
Closed -$131 – 3437
2025
Q2 		$131 Buy
+2
New +$130 ﹤0.01% 3130

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's ANIP Position: Q2 2026 in Review

Larson Financial Group increased its ANI Pharmaceuticals (ANIP) stake by 44% in Q2 2026, buying an estimated $8.02K and bringing the position to 328 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Larson Financial Group first reported a position in ANIP in Q2 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Larson Financial Group held 328 shares of ANI Pharmaceuticals worth $27.2K as of Q2 2026.
  • Larson Financial Group bought 100 ANI Pharmaceuticals shares in Q2 2026, an estimated $8.02K.
  • ANI Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1834 holding.
  • Larson Financial Group first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.